Fanconi Anemia: Clinical Trials

3 trials for Fanconi Anemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Unknown 1
Phase 22Completed 2

Follow Fanconi Anemia: new trials by email Literature Review of Fanconi Anemia trials Research Report on Fanconi Anemia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Metformin for Treatment of Cytopenia in Children and Adolescents With Fanconi Anemia
Metformin - Fanconi Anemia
Phase 3UnknownAin Shams University302022-10-052024-07-25
TBI Dose De-escalation for Fanconi Anemia
Cyclophosphamide, Fludarabine, Total Body Irradiation - Fanconi Anemia
Phase 2 / Phase 3CompletedMasonic Cancer Center, University of Minnesota832006-05-182021-11-24
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases
Fludarabine, Cyclophosphamide, Busulfan - Bone Marrow Failure, Osteopetrosis
Phase 2 / Phase 3CompletedColumbia University382002-09-012024-10-31

Narrower conditions

Bone Marrow Failure Disorders (1)  ·  Osteopetrosis (1)  ·  Severe Combined Immunodeficiency (1)

Broader conditions

Anemia (3)  ·  Anemia, Aplastic (3)  ·  Anemia, Hypoplastic, Congenital (3)  ·  Bone Marrow Diseases (3)  ·  Congenital Bone Marrow Failure Syndromes (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  DNA Repair-Deficiency Disorders (3)  ·  Genetic Diseases, Inborn (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Bone Marrow Failure Disorders (2)  ·  Bone Diseases (1)  ·  Bone Diseases, Developmental (1)

Interventions

Cyclophosphamide (2)  ·  fludarabine (2)  ·  fludarabine phosphate (2)  ·  Alemtuzumab (1)  ·  Antilymphocyte Serum (1)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Metformin (1)  ·  Mycophenolic Acid (1)  ·  Radiotherapy (1)  ·  Sirolimus (1)  ·  Stem Cell Transplantation (1)  ·  Whole-Body Irradiation (1)  ·  thymoglobulin (1)

Sponsors

Ain Shams University (1)  ·  Columbia University (1)  ·  Masonic Cancer Center, University of Minnesota (1)

Countries

United States (2)  ·  Egypt (1)

Top investigators

James Garvin, MD, PhD (1)  ·  Margaret L MacMillan, M.D. (1)